abstract |
A method of treating HBV or HIV infections comprising administering to an individual an effective amount of the compound of formula IId′: n n wherein R 2 is the residue of an aliphatic L-amino acid, p is 0, 1, or 2-20, and q is 0, or a pharmaceutically acceptable salt thereof. |